Evidence map›Paper›PMID 40223258›Full record

ArticleClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology2025

Association of Cognitive Impairment and Peripheral Inflammation in Methamphetamine-dependent Patients: A Cross-sectional Study on Neuroinflammatory Markers TNF-α and IL-6.

Kannika Permpoonputtana, Jatuporn Namyen, Doungjai Buntup, Parichart Boontem, Chutikorn Nopparat, Piyarat Govitrapong

Abstract read
In one paragraph

Article in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Observational
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kannika PermpoonputtanaNational Institute for Child and Family Development, Mahidol University, Nakhon Pathom, Thailand.ORCID https://orcid.org/0000-0001-6442-8629
Jatuporn NamyenBrain, Mind and Learning Research and Development Unit, Department of Research and Applied Psychology, Faculty of Education, Burapha University, Chonburi, Thailand.ORCID https://orcid.org/0000-0001-8791-9543
Doungjai BuntupAddiction Studies Program, ASEAN Institute for Health Development, Mahidol University, Nakhon Pathom, Thailand.ORCID https://orcid.org/0000-0002-7092-6883
Parichart BoontemChulabhorn Graduate Institute, Chulabhorn Royal Academy, Bangkok, Thailand.ORCID https://orcid.org/0000-0002-5171-5634
Chutikorn NopparatInnovative Learning Center, Srinakharinwirot University, Bangkok, Thailand.ORCID https://orcid.org/0000-0001-7984-3948
Piyarat GovitrapongChulabhorn Graduate Institute, Chulabhorn Royal Academy, Bangkok, Thailand.ORCID https://orcid.org/0000-0002-9403-6252

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the cognitive impairment and peripheral inflammation induced by methamphetamine (METH) and their association in METH abusers. Methods: The cross-sectional study included 100 METH-dependent patients and 100 healthy controls. Cognitive screening was conducted using the Thai version of the Montreal Cognitive Assessment (MoCA-T). Thirty normal controls and 30 METH-dependent patients were randomly selected for blood collection to measure inflammatory markers, including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, using a quantitative enzyme-linked immunosorbent assay method. Results: METH-dependent patients had significantly poorer MoCA-T scores and higher levels of blood inflammatory markers compared to healthy controls. Demographic characteristics, METH use patterns, and proinflammatory cytokines were associated with cognitive impairment. The MoCA-T score was negatively associated with plasma TNF-α and IL-6 levels. Conclusion: METH-associated cognitive decline is correlated with elevated plasma levels of TNF-α and IL-6 cytokines, indicating the involvement of specific neuroinflammatory pathways in neurocognitive dysfunction. These insights could pave the way for novel therapeutic strategies aimed at mitigating neuroinflammation, potentially improving outcomes for individuals with METH addiction.

Indexed as

Cognitive dysfunctionCytokinesInterleukin-1 betaInterleukin-6MethamphetamineTumor necrosis factor-alpha

Identifiers

PMID40223258
PMCPMC12000663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.